Cowen and Company’s SBC Medical Group Warrants SBCWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-149,910
Closed -$22.5K 413
2024
Q3
$22.5K Buy
149,910
+89,910
+150% +$9.3K ﹤0.01% 419
2024
Q2
$4.26K Buy
60,000
+10,000
+20% +$728 ﹤0.01% 532
2024
Q1
$1.75K Hold
50,000
﹤0.01% 639
2023
Q4
$1.41K Sell
50,000
-10,093
-17% -$405 ﹤0.01% 543
2023
Q3
$3.6K Sell
60,093
-100
-0.2% -$5 ﹤0.01% 557
2023
Q2
$3.58K Sell
60,193
-65,988
-52% -$3.1K ﹤0.01% 493
2023
Q1
$5.98K Sell
126,181
-380
-0.3% -$25 ﹤0.01% 447
2022
Q4
$6.97K Sell
126,561
-10,100
-7% -$469 ﹤0.01% 441
2022
Q3
$13K Buy
+136,661
New +$11.4K ﹤0.01% 392

Other funds holding SBCWW

Cowen and Company's SBCWW Position: Q4 2024 in Review

Cowen and Company sold out of SBC Medical Group Warrants (SBCWW) in Q4 2024, closing a stake of 149,910 shares — an estimated $22.5K sold.

Cowen and Company first reported a position in SBCWW in Q3 2022 and held it in 9 quarters. The position peaked at $22.5K in Q3 2024. 22 funds tracked by Wall St. Rank hold SBCWW as of Q4 2024.

  • Cowen and Company reported no remaining SBC Medical Group Warrants position as of Q4 2024 after selling out during the quarter.
  • Cowen and Company sold 149,910 SBC Medical Group Warrants shares in Q4 2024, an estimated $22.5K.
  • Cowen and Company first reported a position in SBC Medical Group Warrants in Q3 2022 and held it in 9 quarters.
  • Cowen and Company's SBC Medical Group Warrants position peaked at $22.5K in Q3 2024.
  • 22 funds tracked by Wall St. Rank held SBC Medical Group Warrants as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.